MINERALYS THERAPEUTICS, INC. Shares Outstanding (Cover Page)
MINERALYS THERAPEUTICS, INC. (MLYS) had Shares Outstanding (Cover Page) of 88.41 million shares as of 2026-08-03, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-03: Entity Common Stock, Shares Outstanding 88.41M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 82.50M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 82.40M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 79.14M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 88.41M shares 10-Q · filed 2026-08-11 |
| 2026-04-27 | 82.50M shares 10-Q · filed 2026-05-06 |
| 2026-03-05 | 82.40M shares 10-K · filed 2026-03-12 |
| 2025-11-03 | 79.14M shares 10-Q · filed 2025-11-10 |
| 2025-08-07 | 66.30M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 65.18M shares 10-Q · filed 2025-05-12 |
| 2025-02-07 | 49.84M shares 10-K · filed 2025-02-12 |
| 2024-11-04 | 49.77M shares 10-Q · filed 2024-11-12 |
| 2024-08-02 | 49.73M shares 10-Q · filed 2024-08-13 |
| 2024-05-01 | 49.65M shares 10-Q · filed 2024-05-09 |
| 2024-03-15 | 49.63M shares 10-K · filed 2024-03-21 |
| 2023-11-01 | 41.11M shares 10-Q · filed 2023-11-07 |
| 2023-08-01 | 40.86M shares 10-Q · filed 2023-08-07 |
| 2023-05-05 | 40.86M shares 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |